Preview

Russian Journal of Cardiology

Advanced search

Comparative analysis of echocardiographic and electrocardiographic data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”)

https://doi.org/10.15829/1560-4071-2022-4855

Abstract

Aim. To carry out comparative analysis of echocardiographic and electrocardiographic (ECG) data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”).

Material and methods. The study presents the results of a sub-analysis of the international AKTIV registry, which was called AKTIV CARDIO. Data were collected from 9 medical centers in the Russian Federation. AKTIV CARDIO included 973 hospitalized patients, of which 50 patients died during hospitalization.

Results. Comparative analysis of echocardiographic parameters revealed that 4 parameters differed in deceased patients compared to survivors: left ventricular ejection fraction (LVEF), right ventricular end diastolic dimension (RV EDD), right atrial (RA) short axis diameter and pulmonary artery systolic pressure (PASP). RA short axis diameter was higher in deceased patients compared with survivors (38,0 [36,0; 39,0] versus 35,0 [33,0; 38,0] mm, p=0,011). RV EDD was higher in deceased patients than in survivors (3,0 [29,0; 33,0] vs 28,0 [27,0; 32,0] mm, p=0,019). LVEF was lower in deceased patients compared with survivors (55 [52; 55] vs 60 [56; 65]%, p<0,001). PASP was higher in deceased patients compared with survivors (25 [21; 35] vs 20 [19; 25] mm Hg, p=0,006). Correlation analysis found that the largest number of correlations with markers of the infection severity was observed for RA short axis diameter and RV EDD. A comparative analysis of ECG data revealed that in deceased patients, compared with survivors, atrial fibrillation (AF) (21,4% vs 6,06%, p=0,001) and supraventricular premature beats (14,3% vs 3,36%, р=0,004) occurred more often. In addition, deceased patients had longer QTc interval (440 [416; 450] vs 400 [380; 430] ms, p<0,001).

Conclusion. Comparative analysis of echocardiographic data showed that deceased patients have more pronounced right heart remodeling, higher PASP and lower LVEF. Patient survival was related to RV and RA sizes. Right heart enlargement was associated with markers of infection severity. Echocardiographic parameters characterizing the right heart side can probably be independent prognostic factors in the acute COVID-19 period.

About the Authors

G. P. Arutyunov
Eurasian Association of Therapists; Pirogov Russian National Research Medical University
Russian Federation

MD, PhD, professor, corresponding member of the Russian Academy of Sciences, President

Moscow



E. I. Tarlovskaya
Eurasian Association of Therapists; Privolzhsky Research Medical University
Russian Federation

MD, PhD, Professor, head of the Department of therapy and cardiology, chairperson of the branch in Nizhny Novgorod

Moscow, Nizhny Novgorod



A. G. Arutyunov
Eurasian Association of Therapists; Pirogov Russian National Research Medical University
Russian Federation

MD, PhD, secretary general, professor at  the department of propedeutics of internal diseases, pediatric School

Moscow



Y. N. Belenkov
I.M. Sechenov First Moscow State Medical University
Russian Federation

Academician of the Russian Academy of Sciences, MD, PhD, head of Department of hospital therapy №1 medical faculty

Moscow



A. O. Konradi
Almazov National Medical Research Centre
Russian Federation

Corresponding member of the Russian Academy of Sciences, MD, PhD, Professor, Deputy General Director of scientific work 

St. Petersburg



Y. M. Lopatin
Volgograd State Medical University
Russian Federation

MD, PhD, professor, head of the departrment of cardiology and functional diagnostics, faculty of advanced training for physicians

Volgograd



A. P. Rebrov
V.I. Razumovsky Saratov State Medical University
Russian Federation

PhD, MD, professor at the department of internal medicine

Saratov



S. N. Tereshchenko
National Medical Research Center of Cardiology
Russian Federation

MD, PhD, professor, head at the department of myocardial diseases and heart failure 

Moscow



A. I. Chesnikova
Rostov State Medical University
Russian Federation

MD, PhD, professor, professor at the department of internal medicine No.1

Rostov-on-Don



A. R. Vaisberg
Privolzhsky Research Medical University
Russian Federation

PhD, associate professor at the department of therapy and cardiology

Nizhny Novgoro



N. Y. Grigorieva
Lobachevsky State University of Nizhny Novgorod — National Research University
Russian Federation

MD, PhD, associate professor, head of the department of clinical medicine 

Nizhny Novgorod



B. B. Ogurlieva
Pirogov Russian National Research Medical University; City Clinical Hospital № 24
Russian Federation

PhD student, сardiologist

Moscow



I. V. Fomin
Privolzhsky Research Medical University
Russian Federation

MD, PhD, associate professor, head of the department of hospital therapy

Nizhny Novgorod



I. A. Frolova
Volga Region Medical Center of the Federal Medical and Biological Agency of Russia
Russian Federation

Cardiologist

Nizhny Novgorod



O. Yu. Badina
Volga Region Medical Center of the Federal Medical and Biological Agency of Russia
Russian Federation

Head of the infectious diseases department

Nizhny Novgorod



O. E. Vilkova
Lobachevsky State University of Nizhny Novgorod — National Research University
Russian Federation

PhD, senior lecturer at the department of clinical medicine 

Nizhny Novgorod



N. V. Zarechnova
Volga Region Medical Center of the Federal Medical and Biological Agency of Russia
Russian Federation

Deputy chief physician

Nizhny Novgorod



N. A. Kamardina
Volga Region Medical Center of the Federal Medical and Biological Agency of Russia
Russian Federation

Cardiologist

Nizhny Novgorod



E. V. Koroleva
Lobachevsky State University of Nizhny Novgorod — National Research University; City Clinical Hospital № 5
Russian Federation

Physician of the department of cardiology #2 , assistant at the department of of clinical medicine

Nizhny Novgorod



K. V. Mazalov
Volga Region Medical Center of the Federal Medical and Biological Agency of Russia
Russian Federation

Head of the department of cardiology

Nizhny Novgorod



D. V. Soloveva
Lobachevsky State University of Nizhny Novgorod — National Research University
Russian Federation

Assistant at the department of of clinical medicine

Nizhny Novgorod



References

1. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. International register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AСTIV) and the register “Analysis of hospitalizations of comorbid patients infected during the second wave of SARSCoV-2 outbreak” (AСTIV 2). Russian Journal of Cardiology. 2021;26(3):4358. (In Russ.) doi:10.15829/1560-4071-2021-4358.

2. Arutyunov GP, Tarlovskaya EI, Arutyunov AG, et al. international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors” (AKTIV SARS-CoV-2): analysis of predictors of short-term adverse outcomes in COVID-19. Russian Journal of Cardiology. 2021;26(4):4470. (In Russ.) doi:10.15829/1560-4071-2021-4470.

3. Barman HA, Atici A, Tekin EA, et al. Echocardiographic features of patients with COVID19 infection: a cross-sectional study. Int J Cardiovasc Imaging. 2021;37(3):825-34. doi:10.1007/s10554-020-02051-9.

4. Szekely Y, Lichter Y, Taieb P, et al. Spectrum of Cardiac Manifestations in COVID-19: A Systematic Echocardiographic Study. Circulation. 2020;142(4):342-53. doi:10.1161/CIRCULATIONAHA.120.047971.

5. Golukhova EZ, Slivneva IV, Rybka MM, et al. Right ventricular systolic dysfunction as a predictor of adverse outcome in patients with COVID-19. Kardiologiia. 2020;60(11):16- 29. (In Russ.) doi:10.18087/cardio.2020.11.n1303.

6. Kim J, Volodarskiy A, Sultana R, et al. Prognostic Utility of Right Ventricular Remodeling Over Conventional Risk Stratification in Patients With COVID-19. J Am Coll Cardiol. 2020;76(17):1965-77. doi:10.1016/j.jacc.2020.08.066.

7. Golukhova EZ, Slivneva IV, Rybka MM, et al. Pulmonary hypertension as a risk assessment factor for unfavorable outcome in patients with COVID-19. Russian Journal of Cardiology. 2020;25(12):4136. (In Russ.) doi:10.15829/1560-4071-2020-4136.

8. Chistyakova MV, Zaitsev DN, Govorin AV, et al. Post-COVID-19 syndrome: morphofunctional abnormalities of the heart and arrhythmias. Russian Journal of Cardiology. 2021;26(7):4485. (In Russ.) doi:10.15829/1560-4071-2021-4485.

9. Kovtyukh IV, Gendlin GE, Nikitin IG, et al. The value of indicators characterizing the state of the cardiovascular system in assessing the hospital prognosis of COVID-19 patients. Kardiologiia. 2021;61(10):26-35. (In Russ.) doi:10.18087/cardio.2021.10.n1553.

10. Krishnamoorthy P, Croft LB, Ro R, et al. Biventricular strain by speckle tracking echocardiography in COVID-19: findings and possible prognostic implications. Future Cardiol. 2021;17(4):663-7. doi:10.2217/fca-2020-0100.

11. Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA), Cardiovascular Research. 2021;117(14):2705-29. doi:10.1093/cvr/cvab298.

12. Peng Q-Y, Wang X-T, Zhang L-N. Using echocardiography to guide the treatment of novel coronavirus pneumonia. Crit Care. 2020;24(1):143. doi:10.1186/s13054-020-02856-z.

13. Kirkpatrick JN, Grimm R, Johri AM, et al. Recommendations for echocardiography laboratories participating in cardiac point of care cardiac ultrasound (POCUS) and critical care echocardiography training: report from the american society of echocardiography. J Am Soc Echocardiogr. 2020;33(4):409-22. doi:10.1016/j.echo.2020.01.008.

14. Rosén J, Noreland M, Stattin K, et al.; Uppsala Intensive Care COVID-19 Research Group. ECG pathology and its association with death in critically ill COVID-19 patients, a cohort study. PLoS One. 2021;16(12):e0261315. doi:10.1371/journal.pone.0261315.


Supplementary files

Review

For citations:


Arutyunov G.P., Tarlovskaya E.I., Arutyunov A.G., Belenkov Y.N., Konradi A.O., Lopatin Y.M., Rebrov A.P., Tereshchenko S.N., Chesnikova A.I., Vaisberg A.R., Grigorieva N.Y., Ogurlieva B.B., Fomin I.V., Frolova I.A., Badina O.Yu., Vilkova O.E., Zarechnova N.V., Kamardina N.A., Koroleva E.V., Mazalov K.V., Soloveva D.V. Comparative analysis of echocardiographic and electrocardiographic data of survivors and deceased patients with COVID-19 (sub-analysis of the international register “Dynamics analysis of comorbidities in SARS-CoV-2 survivors”). Russian Journal of Cardiology. 2022;27(3):4855. (In Russ.) https://doi.org/10.15829/1560-4071-2022-4855

Views: 1876


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)